drugset / Trial / NCT01687478
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of olanzapine and fluoxetine compared to placebo and fluoxetine as treatment for treatment-resistant depression (TRD) in Chinese participants.
Timeline
- Start
- 2012-09
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 15 mg | Oral |
| Background | Fluoxetine | Small molecule | 50 mg | Oral |
Indications
No indication recorded.